Critical Update of the 2010 Endocrine Society Clinical Practice Guidelines for Male Hypogonadism A Systematic Analysis

Mayo Clinic Proceedings

Volumn 90, Issue 8, 2015, Pages 1104-1115

  Seftel, Allen D ^a   Kathrins, Martin ^b   Niederberger, Craig ^b  

^a Rowan University ^*  (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TESTOSTERONE UNDECANOATE; ANDROGEN; TESTOSTERONE;

ANDROGEN THERAPY; BONE DENSITY; CARDIOVASCULAR DISEASE; CLINICAL TRIAL (TOPIC); COMORBIDITY; DRUG EFFICACY; DRUG SAFETY; ERECTILE DYSFUNCTION; FRAILTY; HUMAN; HYPOGONADISM; INSULIN SENSITIVITY; LOWER URINARY TRACT SYMPTOM; MALE; META ANALYSIS (TOPIC); METABOLIC SYNDROME X; MORBIDITY; MULTICENTER STUDY (TOPIC); MUSCLE STRENGTH; NON INSULIN DEPENDENT DIABETES MELLITUS; OSTEOPOROSIS; PARAMETERS; PRACTICE GUIDELINE; PROSTATE CANCER; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SEXUAL FUNCTION; SLEEP DISORDERED BREATHING; SYSTEMATIC REVIEW (TOPIC); THERAPY EFFECT; TREATMENT CONTRAINDICATION; TREATMENT DURATION; TREATMENT RESPONSE; WELLBEING; COMPLICATION; MEDICAL SOCIETY; RISK ASSESSMENT;

ANDROGENS; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; ERECTILE DYSFUNCTION; HUMANS; HYPOGONADISM; MALE; PRACTICE GUIDELINES AS TOPIC; RISK ASSESSMENT; SOCIETIES, MEDICAL; TESTOSTERONE;

EID: 84938741317     PISSN: 00256196     EISSN: 19425546     Source Type: Journal    
DOI: 10.1016/j.mayocp.2015.06.002     Document Type: Review

References (38)

1. S.M. Harman, E.J. Metter, J.D. Tobin, J.A.Y. Pearson, and M.R. Blackman Longitudinal effects of aging on serum total and free testosterone levels in healthy men J Clin Endocrinol Metab 86 2 2001 724 731
2. J. Baillargeon, R.J. Urban, K.J. Ottenbacher, K.S. Pierson, and J.S. Goodwin Trends in androgen prescribing in the United States, 2001 to 2011 JAMA Intern Med 173 15 2014 2013 2014
3. S. Bhasin, G.R. Cunningham, F.J. Hayes, and et al. Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline J Clin Endocrinol Metab 95 6 2010 2536 2559
4. Bone, Reproductive, and Urologic Drugs Advisory Committee, Food and Drug Administration. Update: FDA cautions about using testosterone products for low testosterone due to aging; requires labeling change to inform of possible increased risk of heart attack and stroke with use. http://www.fda.gov/downloads/Drugs/DrugSafety/UCM436270.pdf. Published March 3, 2015. Accessed March 15, 2015.
5. D. Moher, A. Liberati, J. Tetzlaff, and D.G. Altman Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement Int J Surg 8 5 2010 336 341
6. S.E. Canfield, and P. Dahm Rating the quality of evidence and the strength of recommendations using GRADE World J Urol 29 3 2011 311 317
7. R.M. Turpen, S.F. Fesperman, S. Sultan, and et al. Levels of evidence ratings in the urological literature: an assessment of interobserver agreement BJU Int 105 5 2010 602 606
8. J.P.T. Higgins, D.G. Altman, P.C. Gotzsche, and et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials BMJ 343 2011 d5928
9. C.M. Hoyos, R. Killick, B.J. Yee, R.R. Grunstein, and P.Y. Liu Effects of testosterone therapy on sleep and breathing in obese men with severe obstructive sleep apnoea: a randomized placebo-controlled trial Clin Endocrinol (Oxf) 77 4 2012 599 607
10. R.O.O. Killick, D. Wang, and C.M. Hoyos Obstructive sleep apnea: the effects of testosterone on ventilatory responses in men with obstructive sleep apnea: a randomised, placebo-controlled trial J Sleep Res 22 3 2013 331 336
11. K.L. Hildreth, D.W. Barry, K.L. Moreau, and et al. Effects of testosterone and progressive resistance exercise in healthy, highly functioning older men with low-normal testosterone levels J Clin Endocrinol Metab 98 5 2013 1891 1900
12. E. Del Fabbro, J.M. Garcia, R. Dev, and et al. Testosterone replacement for fatigue in hypogonadal ambulatory males with advanced cancer: a preliminary double-blind placebo-controlled trial Support. Care Cancer 21 9 2013 2599 2607
13. A.M. Kenny, A. Kleppinger, K. Annis, and et al. Effects of transdermal testosterone on bone and muscle in older men with low bioavailable testosterone levels, low bone mass, and physical frailty J Gerontol A Biol Sci Med Sci 56 5 2010 1134 1143
14. S.Y. Kalinchenko, Y.A. Tishova, G.J. Mskhalaya, and et al. Effects of testosterone supplementation on markers of the metabolic syndrome and inflammation in hypogonadal men with the metabolic syndrome: the double-blinded placebo controlled Moscow study Clin Endocrinol (Oxf) 73 5 2010 602 612
15. U. Srinivas-Shankar, S.A. Roberts, M.J. Connolly, and et al. Effects of testosterone on muscle strength, physical function, body composition, and quality of life in intermediate-frail and frail elderly men: a randomized, double-blind, placebo-controlled study J Clin Endocrinol Metab 95 2 2010 639 650
16. W.S. Tan, W.Y. Low, C.J. Ng, and et al. Efficacy and safety of long-acting intramuscular testosterone undecanoate in aging men: a randomised controlled study BJU Int 111 7 2013 1130 1140
17. M. Stout, G.A. Tew, H. Doll, and et al. Testosterone therapy during exercise rehabilitation in male patients with chronic heart failure who have low testosterone status: a double-blind randomized controlled feasibility study Am Heart J 164 6 2012 893 901
18. G. Hackett, N. Cole, M. Bhartia, D. Kennedy, J. Raju, and P. Wilkinson Testosterone replacement therapy with long-acting testosterone undecanoate improves sexual function and quality-of-life parameters vs. placebo in a population of men with type 2 diabetes J Sex Med 10 6 2013 1612 1627
19. G. Hackett, N. Cole, M. Bhartia, D. Kennedy, J. Raju, and P. Wilkinson Testosterone replacement therapy improves metabolic parameters in hypogonadal men with type 2 diabetes but not in men with coexisting depression: the BLAST study J Sex Med 11 3 2014 840 856
20. T.H. Jones, S. Arver, H.M.H. Behre, and et al. Testosterone replacement in hypogonadal men with type 2 diabetes and/or metabolic syndrome (the TIMES2 study) Diabetes Care 34 4 2011 828 837
21. A. Aversa, R. Bruzziches, D. Francomano, and et al. Effects of testosterone undecanoate on cardiovascular risk factors and atherosclerosis in middle-aged men with late-onset hypogonadism and metabolic syndrome: results from a 24-month, randomized, double-blind, placebo-controlled study J Sex Med 7 10 2010 3495 3503
22. E.J. Gianatti, P. Dupuis, R. Hoermann, and et al. Effect of testosterone treatment on glucose metabolism in men with type 2 diabetes: a randomized controlled trial Diabetes Care 37 8 2014 2098 2107
23. E.J. Gianatti, P. Dupuis, R. Hoermann, J.D. Zajac, and M. Grossmann Effect of testosterone treatment on constitutional and sexual symptoms in men with type 2 diabetes in a randomized, placebo-controlled clinical trial J Clin Endocrinol Metab 99 10 2014 3821 3828
24. R.A. Gopal, N. Bothra, S.V. Acharya, and et al. Treatment of hypogonadism with testosterone in patients with type 2 diabetes mellitus Endocr Pract 16 4 2010 570 576
25. S.-F. Tong, C.-J. Ng, B.-C. Lee, and et al. Effect of long-acting testosterone undecanoate treatment on quality of life in men with testosterone deficiency syndrome: a double blind randomized controlled trial Asian J Androl 14 4 2012 604 611
26. H.G. Pope, R. Amiaz, B.P. Brennan, and et al. Parallel-group placebo-controlled trial of testosterone gel in men with major depressive disorder displaying an incomplete response to standard antidepressant treatment J Clin Psychopharmacol 30 2 2010 126 134
27. R. Amiaz, H.G. Pope Jr., T. Mahne, and et al. Testosterone gel replacement improves sexual function in depressed men taking serotonergic antidepressants: a randomized, placebo-controlled clinical trial J Sex Marital Ther 37 4 2011 243 254
28. J. Buvat, F. Montorsi, M. Maggi, and et al. Hypogonadal men nonresponders to the PDE5 inhibitor tadalafil benefit from normalization of testosterone levels with a 1% hydroalcoholic testosterone gel in the treatment of erectile dysfunction (TADTEST study) J Sex Med 8 1 2011 284 293
29. M. Spitzer, S. Basaria, T.G. Travison, M.N. Davda, L. Derogatis, and S. Bhasin The effect of testosterone on mood and well-being in men with erectile dysfunction in a randomized, placebo-controlled trial Andrology 1 3 2013 475 482
30. M. Spitzer, S. Basaria, T.G. Travison, and et al. Effect of testosterone replacement on response to sildenafil citrate in men with erectile dysfunction Ann Intern Med 157 10 2012 681 691
31. O.M. Calof, A.B. Singh, M.L. Lee, and et al. Adverse events associated with testosterone replacement in middle-aged and older men: a meta-analysis of randomized, placebo-controlled trials J Gerontol 60 11 2005 1451 1457
32. S. Basaria, A. Coviello, and T.G. Travison Adverse events associated with testosterone administration N Engl J Med 363 2 2010 109 122
33. S. Basaria, M.N. Davda, T.G. Travison, J. Ulloor, R. Singh, and S. Bhasin Risk factors associated with cardiovascular events during testosterone administration in older men with mobility limitation J Gerontol A Biol Sci Med Sci 68 2 2013 153 160
34. R.A. Atkinson, U. Srinivas-Shankar, S.A. Roberts, and et al. Effects of testosterone on skeletal muscle architecture in intermediate-frail and frail elderly men J Gerontol A Biol Sci Med Sci 65 11 2010 1215 1219
35. C.M. Hoyos, B.J. Yee, C.L. Phillips, E.A. Machan, R.R. Grunstein, and P.Y. Liu Body compositional and cardiometabolic effects of testosterone therapy in obese men with severe obstructive sleep apnoea: a randomised placebo-controlled trial Eur J Endocrinol 167 4 2012 531 541
36. R. Vigen, C.I. O'Donnell, A.E. Baron, and et al. Association of testosterone therapy with mortality, myocardial Infarction, and stroke in men with low testosterone levels JAMA 310 17 2013 1829
37. W.D. Finkle, S. Greenland, G.K. Ridgeway, and et al. Increased risk of non-fatal myocardial infarction following testosterone therapy prescription in men PLoS One 9 1 2014 1 7
38. J. Baillargeon, R.J. Urban, Y.-F. Kuo, and et al. Risk of myocardial infarction in older men receiving testosterone therapy Ann Pharmacother 48 9 2014 1138 1144